Heuristic modeling of macromolecule release from PLGA microspheres

Dissolution of protein macromolecules from poly(lactic-co-glycolic acid) (PLGA) particles is a complex process and still not fully understood. As such, there are difficulties in obtaining a predictive model that could be of fundamental significance in design, development, and optimization for medical applications and toxicity evaluation of PLGA-based multiparticulate dosage form. In the present study, two models with comparable goodness of fit were proposed for the prediction of the macromolecule dissolution profile from PLGA micro- and nanoparticles. In both cases, heuristic techniques, such as artificial neural networks (ANNs), feature selection, and genetic programming were employed. Feature selection provided by fscaret package and sensitivity analysis performed by ANNs reduced the original input vector from a total of 300 input variables to 21, 17, 16, and eleven; to achieve a better insight into generalization error, two cut-off points for every method was proposed. The best ANNs model results were obtained by monotone multi-layer perceptron neural network (MON-MLP) networks with a root-mean-square error (RMSE) of 15.4, and the input vector consisted of eleven inputs. The complicated classical equation derived from a database consisting of 17 inputs was able to yield a better generalization error (RMSE) of 14.3. The equation was characterized by four parameters, thus feasible (applicable) to standard nonlinear regression techniques. Heuristic modeling led to the ANN model describing macromolecules release profiles from PLGA microspheres with good predictive efficiency. Moreover genetic programming technique resulted in classical equation with comparable predictability to the ANN model.

[1]  A. Lamprecht,et al.  Influence of PEG in PEG-PLGA microspheres on particle properties and protein release. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[2]  John C. Nash,et al.  Unifying Optimization Algorithms to Aid Software System Users: optimx for R , 2011 .

[3]  M. Alonso,et al.  Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. , 1998, Journal of controlled release : official journal of the Controlled Release Society.

[4]  María J. Alonso,et al.  Development and characterization of protein-loaded poly(lactide-co-glycolide) nanospheres , 1997 .

[5]  C. H. Wang,et al.  Release of paclitaxel from polylactide-co-glycolide (PLGA) microparticles and discs under irradiation , 2003 .

[6]  K. Griebenow,et al.  Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation. , 2006, Journal of pharmaceutical sciences.

[7]  Hao Ying,et al.  Essentials of fuzzy modeling and control , 1995 .

[8]  M. Ghanei,et al.  Encapsulation of Alpha-1 antitrypsin in PLGA nanoparticles: In Vitro characterization as an effective aerosol formulation in pulmonary diseases , 2012, Journal of Nanobiotechnology.

[9]  O. Corrigan,et al.  Quantifying drug release from PLGA nanoparticulates. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[10]  Shufen Ma,et al.  Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer. , 2011, International journal of pharmaceutics.

[11]  Ying Wang,et al.  Pharmacokinetic and pharmacodynamic profiles of recombinant human erythropoietin-loaded poly(lactic-co-glycolic acid) microspheres in rats , 2011, Acta Pharmacologica Sinica.

[12]  K. Zhu,et al.  Improvement of protein loading and modulation of protein release from poly(lactide-co-glycolide) microspheres by complexation of proteins with polyanions , 2004, Journal of microencapsulation.

[13]  J. Emami,et al.  Pharmacokinetics and pharmacodynamics of controlled release insulin loaded PLGA microcapsules using dry powder inhaler in diabetic rats , 2010, Biopharmaceutics & drug disposition.

[14]  Steven P Schwendeman,et al.  Pore closing and opening in biodegradable polymers and their effect on the controlled release of proteins. , 2007, Molecular pharmaceutics.

[15]  M. Alonso,et al.  Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[17]  O. Corrigan,et al.  An Investigation of the Mechanism of Release of the Amphoteric Drug Amoxycillin from Poly(d,l-Lactide-co-glycolide) Matrices , 2002, Pharmaceutical development and technology.

[18]  T. Park,et al.  Microencapsulation of dissociable human growth hormone aggregates within poly(D,L-lactic-co-glycolic acid) microparticles for sustained release. , 2001, International journal of pharmaceutics.

[19]  E. Topp,et al.  Physical properties of PLGA films during polymer degradation , 2009 .

[20]  Juergen Siepmann,et al.  A New Mathematical Model Quantifying Drug Release from Bioerodible Microparticles Using Monte Carlo Simulations , 2002, Pharmaceutical Research.

[21]  V. Préat,et al.  PLGA-based nanoparticles: an overview of biomedical applications. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[22]  A. Göpferich,et al.  Mechanisms of polymer degradation and erosion. , 1996, Biomaterials.

[23]  Anders Axelsson,et al.  The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review. , 2011, International journal of pharmaceutics.

[24]  P. Deluca,et al.  Development of a dialysis in vitro release method for biodegradable microspheres , 2005, AAPS PharmSciTech.

[25]  Tae Gwan Park,et al.  Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[26]  S. De,et al.  Particle size and temperature effect on the physical stability of PLGA nanospheres and microspheres containing Bodipy , 2004, AAPS PharmSciTech.

[27]  Oliver Lambert,et al.  Stability of proteins encapsulated in injectable and biodegradable poly(lactide-co-glycolide)-glucose millicylinders. , 2008, International journal of pharmaceutics.

[28]  Rubiana M Mainardes,et al.  PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. , 2005, International journal of pharmaceutics.

[29]  Hirenkumar K. Makadia,et al.  Poly Lactic-co-Glycolic Acid ( PLGA ) as Biodegradable Controlled Drug Delivery Carrier , 2011 .

[30]  M. L. La Rotonda,et al.  Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[31]  Jacek M. Zurada,et al.  Perturbation method for deleting redundant inputs of perceptron networks , 1997, Neurocomputing.

[32]  Xuesi Chen,et al.  Insulin nanoparticle preparation and encapsulation into poly(lactic-co-glycolic acid) microspheres by using an anhydrous system. , 2009, International journal of pharmaceutics.

[33]  Renata Jachowicz,et al.  Unified methodology of neural analysis in decision support systems built for pharmaceutical technology , 2007, Expert Syst. Appl..

[34]  Mauro Ferrari,et al.  Mesoporous Silicon‐PLGA Composite Microspheres for the Double Controlled Release of Biomolecules for Orthopedic Tissue Engineering , 2012 .

[35]  Martin Crane,et al.  Quantitative multi-agent models for simulating protein release from PLGA bioerodible nano- and microspheres. , 2008, Journal of pharmaceutical and biomedical analysis.

[36]  Sebastian Polak,et al.  Generalized in vitro-in vivo relationship (IVIVR) model based on artificial neural networks , 2013, Drug design, development and therapy.

[37]  Tae Gwan Park,et al.  Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres. , 2002, Biomaterials.

[38]  G. Puras,et al.  Encapsulation of Aβ(1-15) in PLGA microparticles enhances serum antibody response in mice immunized by subcutaneous and intranasal routes. , 2011, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[39]  K Zygourakis,et al.  Computer-aided design of bioerodible devices with optimal release characteristics: a cellular automata approach. , 1996, Biomaterials.

[40]  H. Takeuchi,et al.  Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[41]  Jagdish Singh,et al.  Effect of additives on the release of a model protein from PLGA microspheres , 2001, AAPS PharmSciTech.

[42]  P. Weston,et al.  Effect of protein molecular weight on release from micron-sized PLGA microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.